Lynne Marie Sullivan, CFO & Head of Corporate Development at Unity Biotechnology, Inc. (UBX), sold 153 shares at $2.23 ($341) on 2025-02-04, disclosed to the SEC on 2025-02-05.
Scheduled sale ($341) by CFO & Head of Corporate Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| UBX | SELL | 2024-08-06 | $213 | — | Filing → |
| UBX | SELL | 2024-06-26 | $454 | — | Filing → |
| PHGE | BUY | 2021-07-30 | $50K | — | Filing → |